Literature DB >> 19555363

Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis.

M Stetler-Stevenson1, C M Yuan.   

Abstract

Flow cytometric immunophenotypic analysis is a well-recognized and widely accepted adjuvant test to increase the sensitivity and specificity of diagnosis in potential myelodysplastic syndrome (MDS) cases. In addition, flow cytometric analysis provides prognostic information in MDS that is not available from other sources. The flow cytometric findings indicative of MDS and its value is a diagnostic adjunct are discussed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19555363     DOI： 10.1111/j.1751-553X.2009.01176.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


  2 in total

1.  Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.

Authors:  Hooman H Rashidi; Xiangdong Xu; Huan-You Wang; Nelofar Q Shafi; Karuna Rameshkumar; Karen Messer; Brian R Smith; Michal G Rose
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

2.  Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.

Authors:  Suiellen C Reis-Alves; Fabiola Traina; Konradin Metze; Irene Lorand-Metze
Journal:  Diagn Pathol       Date:  2015-04-29       Impact factor: 2.644
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.